Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Corcept Therapeutics
Corcept Therapeutics
Merck Sharp & Dohme LLC
Jiangsu HengRui Medicine Co., Ltd.
NGM Biopharmaceuticals, Inc
Ohio State University Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
University Hospital, Ghent
Corcept Therapeutics
Peking Union Medical College Hospital
Celgene
GOG Foundation
Ohio State University Comprehensive Cancer Center
GOG Foundation
University of Washington
University of California, San Francisco
Accelerated Community Oncology Research Network
Southeastern Gynecologic Oncology